BioSpace News Archive

VoxNeuro provides the only neuroimaging tool that goes beyond diagnosis to inform cognitive rehabilitation.

Enterprises will bring together technology and clinical excellence; Cleveland Clinic to act as League’s Chief Medical Director

Futura Medical plc (AIM: FUM) (the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, today announced that data reported in two abstracts at SMSNA add to the growing body of data supporting the safety and efficacy of the Company’s MED2005 topical gel for the treatment of erectile dysfunction (ED)

Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting at the eCOA/ePRO and IRT event in Philadelphia, Pennsylvania from October 28th to 30th, 2019.

Hyperfine Research Inc. is introducing the world’s first low-cost, point-of-care (POC) magnetic resonance imaging (MRI) system at the American College of Emergency Physicians (ACEP) Scientific Assembly 2019.

Public safety members and first responders are facing challenges today as never before. The toll of the job is exacting and goes far beyond the physical demands.

Women can now receive hormonal birth control directly from Kroger Health pharmacists.

Applied Medical Technology, Inc. (AMT) announced that it has expanded its ColoCare™ product offering to include a 10F MiniACE® Low Profile Antegrade Continence Enema Button.

Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst Capital, RTI International, and Inova Health Systems

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s third quarter 2019 financial results will be released after market close on Monday, November 4, 2019.